Collegium Pharmaceutical Inc (COLL)

Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.29%199.88	193.52	205.45	209.36	188.00
Cost Of Revenue	17.45%89.59	76.27	77.07	80.19	79.62
Gross Profit	5.93%110.29	117.25	128.38	129.17	108.38
	23.44%106.59	86.35	67.62	67.08	73.28
Selling, General, and Administrative	23.44%106.59	86.35	67.64	67.10	73.64
Operating Income/Loss	88.03%3.70	30.90	60.76	62.09	35.11
Income/Loss From Continuing Operations Before Tax	172.21%-13.53	18.74	29.04	43.44	17.03
Income Tax Expense/Benefit, Deferred	639.15%-7.16	-0.97	-10.07	-12.13	-2.91
Income Tax Expense/Benefit	64.21%1.52	4.24	12.07	11.93	5.04
	203.83%-15.05	14.50	16.96	31.51	11.98
Attributable To Parent	203.83%-15.05	14.50	16.96	31.51	11.98
Basic Average Shares	1.16%32.46	32.09	31.65	31.57	31.81
Diluted Average Shares	18.98%32.46	40.07	40.08	39.44	39.08
Basic Earnings Per Share	202.22%-0.46	0.45	0.54	1.00	0.38
Diluted Earnings Per Share	215.00%-0.46	0.40	0.46	0.84	0.34